Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study
Berndt-Zipfel C, Michelson G, Dworak M, Mitry M, Loeffler A, Pfuetzner A, Forst T (2013)
Publication Type: Journal article
Publication year: 2013
Journal
Book Volume: 12
Pages Range: 59
Abstract
Numerous rheological and microvascular alterations characterize the vascular pathology in patients with type 2 diabetes mellitus (T2DM). This study investigated effects of vildagliptin in comparison to glimepiride on retinal microvascular blood flow and erythrocyte deformability in T2DM.
Authors with CRIS profile
Involved external institutions
Switzerland (CH)How to cite
APA:
Berndt-Zipfel, C., Michelson, G., Dworak, M., Mitry, M., Loeffler, A., Pfuetzner, A., & Forst, T. (2013). Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study. Cardiovascular Diabetology, 12, 59. https://doi.org/10.1186/1475-2840-12-59
MLA:
Berndt-Zipfel, Christine, et al. "Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study." Cardiovascular Diabetology 12 (2013): 59.
BibTeX: Download